-
EP2470199
European procedure
Extract from the Register of European Patents
EP About this file: EP2470199
| EP2470199 - DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 27.03.2020 Database last updated on 26.04.2025 | |
| Former | The patent has been granted Status updated on 19.04.2019 | ||
| Former | Grant of patent is intended Status updated on 09.04.2019 | ||
| Former | Examination is in progress Status updated on 20.02.2019 | ||
| Former | Grant of patent is intended Status updated on 08.10.2018 | ||
| Former | Examination is in progress Status updated on 18.09.2018 | ||
| Former | Grant of patent is intended Status updated on 12.04.2018 | Most recent event Tooltip | 01.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 03.08.2022 [2022/31] | Applicant(s) | For all designated states Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place New York, NY 10029 / US | For all designated states Genzyme Corporation 50 Binney Street Cambridge, MA 02142 / US | [2018/39] |
| Former [2018/29] | For all designated states Mount Sinai School of Medicine One Gustave Levy Place New York, NY 10029-6547 / US | ||
| For all designated states Genzyme Corporation 50 Binney Street Cambridge, MA 02142 / US | |||
| Former [2018/19] | For all designated states Mount Sinai School of Medicine One Gustave Levy Place New York, NY 10029-6547 / US | ||
| For all designated states Genzyme Corporation 500 Kendall Street Cambridge, MA 02142 / US | |||
| Former [2012/27] | For all designated states Mount Sinai School of Medicine One Gustave L. Levy Place New York, NY 10029-6547 / US | ||
| For all designated states Genzyme Corporation 500 Kendall Street Cambridge, MA 02142 / US | Inventor(s) | 01 /
SCHUCHMAN, Edward, H. 300 Lakeshore Drive Haworth NJ 07641 / US | 02 /
DESNICK, Robert, J. 170 East 93rd Street New York NY 10128 / US | 03 /
COX, Gerald, F. 48 Avon Circle Needham MA 02494 / US | 04 /
ANDREWS, Laura, P. 32 Farm Road Bolton MA 01740 / US | 05 /
MURRAY, James, M. 42 Wachusett Circle Shrewsbury MA 01545 / US | [2012/27] | Representative(s) | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | [N/P] |
| Former [2012/27] | Weber, Martin, et al Jones Day Prinzregentenstraße 11 80538 München / DE | Application number, filing date | 10812683.0 | 28.08.2010 | [2019/21] | WO2010US47057 | Priority number, date | US20090238113P | 28.08.2009 Original published format: US 238113 P | [2012/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2011025996 | Date: | 03.03.2011 | Language: | EN | [2011/09] | Type: | A2 Application without search report | No.: | EP2470199 | Date: | 04.07.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.03.2011 takes the place of the publication of the European patent application. | [2012/27] | Type: | B1 Patent specification | No.: | EP2470199 | Date: | 22.05.2019 | Language: | EN | [2019/21] | Search report(s) | International search report - published on: | US | 15.03.2012 | (Supplementary) European search report - dispatched on: | EP | 25.02.2013 | Classification | IPC: | A61K38/43, A61P3/06 | [2012/27] | CPC: |
A61K38/465 (EP,CN,IL,KR,US);
A61K38/43 (RU);
A61P1/16 (EP,IL);
A61P11/00 (EP,IL);
A61P25/00 (EP,IL,KR);
A61P25/28 (EP,IL,KR);
A61P3/00 (EP,IL);
A61P3/06 (EP,IL,KR,RU);
A61P43/00 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/27] | Extension states | BA | Not yet paid | ME | Not yet paid | RS | Not yet paid | Title | German: | DOSISERHÖHUNGS- UND ENZYMERSATZTHERAPIE ZUR BEHANDLUNG MANGELNDER SAURER SPHINGOMYELINASE | [2012/27] | English: | DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY | [2012/27] | French: | THÉRAPIE DE SUBSTITUTION ENZYMATIQUE À DOSES CROISSANTES PERMETTANT DE TRAITER UN DÉFICIT EN SPHINGOMYÉLINASE ACIDE | [2012/27] | Entry into regional phase | 19.03.2012 | National basic fee paid | 19.03.2012 | Search fee paid | 19.03.2012 | Designation fee(s) paid | 19.03.2012 | Examination fee paid | Examination procedure | 19.03.2012 | Examination requested [2012/27] | 09.09.2013 | Amendment by applicant (claims and/or description) | 19.12.2014 | Despatch of a communication from the examining division (Time limit: M06) | 22.06.2015 | Reply to a communication from the examining division | 20.04.2016 | Despatch of a communication from the examining division (Time limit: M06) | 27.10.2016 | Reply to a communication from the examining division | 13.04.2018 | Communication of intention to grant the patent | 17.08.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 09.10.2018 | Communication of intention to grant the patent | 19.02.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 19.02.2019 | Fee for grant paid | 19.02.2019 | Fee for publishing/printing paid | 09.04.2019 | Information about intention to grant a patent | 09.04.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18199358.5 / EP3482767 | EP21200695.1 / EP3998078 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 19.12.2014 | Opposition(s) | 25.02.2020 | No opposition filed within time limit [2020/18] | Fees paid | Renewal fee | 10.08.2012 | Renewal fee patent year 03 | 19.08.2013 | Renewal fee patent year 04 | 13.08.2014 | Renewal fee patent year 05 | 27.08.2015 | Renewal fee patent year 06 | 29.08.2016 | Renewal fee patent year 07 | 28.08.2017 | Renewal fee patent year 08 | 27.08.2018 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 22.05.2019 | MK | 22.05.2019 | SM | 22.05.2019 | IS | 22.09.2019 | [2022/31] |
| Former [2021/31] | AL | 22.05.2019 | |
| SM | 22.05.2019 | ||
| IS | 22.09.2019 | ||
| Former [2020/14] | AL | 22.05.2019 | |
| SM | 22.05.2019 | ||
| Former [2019/50] | AL | 22.05.2019 | Documents cited: | Search | [X]WO2007084737 (GENZYME CORP [US], et al); | International search | [Y]US2005048047 (KAKKIS EMIL D [US]); | [Y]US2007280925 (MEEKER DAVID [US], et al) |